α-Synuclein aggregation, seeding and inhibition by scyllo-inositol

Biochemical and Biophysical Research Communications

Volumn 469, Issue 3, 2016, Pages 529-534

  Ibrahim, Tarek ^a,b   McLaurin, JoAnne ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Parkinson's disease; Protein misfolding; scyllo Inositol; Seeding; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PROTEIN; CHIROINOSITOL; INOSITOL DERIVATIVE; MONOMER; PROTEIN INHIBITOR; SCYLLOINOSITOL; UNCLASSIFIED DRUG; INOSITOL; MULTIPROTEIN COMPLEX; PROTEIN BINDING; SCYLLITOL;

AMINO ACID SEQUENCE; ARTICLE; INHIBITION KINETICS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BINDING SITE; CHEMISTRY; MOUSE; SPECIES DIFFERENCE; SYNTHESIS;

ALPHA-SYNUCLEIN; ANIMALS; BINDING SITES; INOSITOL; MICE; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; SPECIES SPECIFICITY;

EID: 84953636182     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.12.043     Document Type: Article

References (22)

1. H. Braak, K. Del Tredici, U. Rub, R.A. de Vos, E.N. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol. Aging 24 2003 197 211
2. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson, and P.T. Lansbury Jr. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl. Acad. Sci. U. S. A. 97 2000 571 576
3. S.J. Wood, J. Wypych, S. Steavenson, J.C. Louis, M. Citron, and A.L. Biere alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease J. Biol. Chem. 274 1999 19509 19512
4. M. Masuda-Suzukake, T. Nonaka, M. Hosokawa, T. Oikawa, T. Arai, H. Akiyama, D.M. Mann, and M. Hasegawa Prion-like spreading of pathological alpha-synuclein in brain Brain A J. Neurol. 136 2013 1128 1138
5. A.N. Sacino, M. Brooks, M.A. Thomas, A.B. McKinney, N.H. McGarvey, N.J. Rutherford, C. Ceballos-Diaz, J. Robertson, T.E. Golde, and B.I. Giasson Amyloidogenic alpha-synuclein seeds do not invariably induce rapid, widespread pathology in mice Acta Neuropathol. 127 2014 645 665
6. J.L. Guo, D.J. Covell, J.P. Daniels, M. Iba, A. Stieber, B. Zhang, D.M. Riddle, L.K. Kwong, Y. Xu, J.Q. Trojanowski, and V.M. Lee Distinct alpha-synuclein strains differentially promote tau inclusions in neurons Cell 154 2013 103 117
7. L. Bousset, L. Pieri, G. Ruiz-Arlandis, J. Gath, P.H. Jensen, B. Habenstein, K. Madiona, V. Olieric, A. Bockmann, B.H. Meier, and R. Melki Structural and functional characterization of two alpha-synuclein strains Nat. Commun. 4 2013 2575
8. W. Peelaerts, L. Bousset, A. Van der Perren, A. Moskalyuk, R. Pulizzi, M. Giugliano, C. Van den Haute, R. Melki, and V. Baekelandt alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration Nature 522 2015 340 344
9. V. Losasso, A. Pietropaolo, C. Zannoni, S. Gustincich, and P. Carloni Structural role of compensatory amino acid replacements in the alpha-synuclein protein Biochemistry 50 2011 6994 7001
10. L. Kang, K.P. Wu, M. Vendruscolo, and J. Baum The A53T mutation is key in defining the differences in the aggregation kinetics of human and mouse alpha-synuclein J. Am. Chem. Soc. 133 2011 13465 13470
11. M.S. Celej, R. Sarroukh, E. Goormaghtigh, G.D. Fidelio, J.M. Ruysschaert, and V. Raussens Toxic prefibrillar alpha-synuclein amyloid oligomers adopt a distinctive antiparallel beta-sheet structure Biochem. J. 443 2012 719 726
12. M. Masuda, N. Suzuki, S. Taniguchi, T. Oikawa, T. Nonaka, T. Iwatsubo, S. Hisanaga, M. Goedert, and M. Hasegawa Small molecule inhibitors of alpha-synuclein filament assembly Biochemistry 45 2006 6085 6094
13. K. Vekrellis, M. Xilouri, E. Emmanouilidou, and L. Stefanis Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death J. Neurochem. 109 2009 1348 1362
14. J. McLaurin, R. Golomb, A. Jurewicz, J.P. Antel, and P.E. Fraser Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity J. Biol. Chem. 275 2000 18495 18502
15. J. McLaurin, M.E. Kierstead, M.E. Brown, C.A. Hawkes, M.H. Lambermon, A.L. Phinney, A.A. Darabie, J.E. Cousins, J.E. French, M.F. Lan, F. Chen, S.S. Wong, H.T. Mount, P.E. Fraser, D. Westaway, and P. St George-Hyslop Cyclohexanehexol inhibitors of abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model Nat. Med. 12 2006 801 808
16. J.C. Rochet, K.A. Conway, and P.T. Lansbury Jr. Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein Biochemistry 39 2000 10619 10626
17. L.A. Volpicelli-Daley, K.C. Luk, and V.M. Lee Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates Nat. Protoc. 9 2014 2135 2146
18. L. Fonseca-Ornelas, S.E. Eisbach, M. Paulat, K. Giller, C.O. Fernandez, T.F. Outeiro, S. Becker, and M. Zweckstetter Small molecule-mediated stabilization of vesicle-associated helical alpha-synuclein inhibits pathogenic misfolding and aggregation Nat. Commun. 5 2014 5857
19. N.R. McFarland, H. Dimant, L. Kibuuka, D. Ebrahimi-Fakhari, C.A. Desjardins, K.M. Danzer, M. Danzer, Z. Fan, M.A. Schwarzschild, W. Hirst, and P.J. McLean Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not alpha-synuclein-induced neuronal cell loss PLoS One 9 2014 e86048
20. S. Daturpalli, C.A. Waudby, S. Meehan, and S.E. Jackson Hsp90 inhibits alpha-synuclein aggregation by interacting with soluble oligomers J. Mol. Biol. 425 2013 4614 4628
21. M.E. Herva, S. Zibaee, G. Fraser, R.A. Barker, M. Goedert, and M.G. Spillantini Anti-amyloid compounds inhibit alpha-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA) J. Biol. Chem. 289 2014 11897 11905
22. G. Li, and R. Pomes Binding mechanism of inositol stereoisomers to monomers and aggregates of Abeta(16-22) J. Phys. Chem. B 117 2013 6603 6613